voxilaprevir hcv ns3 4a protease inhibitor chronic hcv after selected prior daa failure us fda approved in the fixed dose vosevi rescue regimen (Gilead Sciences)
Structured Review

Voxilaprevir Hcv Ns3 4a Protease Inhibitor Chronic Hcv After Selected Prior Daa Failure Us Fda Approved In The Fixed Dose Vosevi Rescue Regimen, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 97/100, based on 178 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selection/Vosevi/pmc13748950-6-0-17
Average 97 stars, based on 178 article reviews
Images
1) Product Images from "Therapeutic and Prophylactic Agents for Viral Diseases: Current Status, Challenges, and Future Prospects"
Article Title: Therapeutic and Prophylactic Agents for Viral Diseases: Current Status, Challenges, and Future Prospects
Journal: MedComm
doi: 10.1002/mco2.71024
Figure Legend Snippet: Chemical structures, molecular targets, and regulatory status of small‐molecule antivirals.
Techniques Used: Protease Inhibitor
Related Articles
Immunopeptidomics:Article Title: A Membrane-Retained DNA Aptamer Promotes Intracellular Platinum Accumulation and Chemosensitization in Ovarian Cancer. Article Snippet: .. Aptamers, short single-stranded DNA or RNA oligonucleotides selected through systematic evolution of ligands by exponential enrichment (SELEX), have emerged as a versatile class of molecular recognition agents.11−13 Compared with conventional antibodies, aptamers possess distinct advantages, such as low immunogenicity, ease of chemical modification, rapid tissue penetration, and scalable synthesis.14−16 CellSELEX, a SELEX variant employing intact living cells as targets, enables the selection of aptamers against native membrane proteins without prior knowledge of the molecular target.17−19 Aptamers generated by Cell-SELEX have shown high potential in diagnostics and therapeutics.20−22 For example, Sgc8, selected against protein tyrosine kinase 7 (PTK7), has been widely used for tumor imaging and targeted drug delivery .23,24 In addition, AS1411, a nucleolin-binding DNA aptamer, has entered phase II clinical trials for Modification:Article Title: A Membrane-Retained DNA Aptamer Promotes Intracellular Platinum Accumulation and Chemosensitization in Ovarian Cancer. Article Snippet: .. Aptamers, short single-stranded DNA or RNA oligonucleotides selected through systematic evolution of ligands by exponential enrichment (SELEX), have emerged as a versatile class of molecular recognition agents.11−13 Compared with conventional antibodies, aptamers possess distinct advantages, such as low immunogenicity, ease of chemical modification, rapid tissue penetration, and scalable synthesis.14−16 CellSELEX, a SELEX variant employing intact living cells as targets, enables the selection of aptamers against native membrane proteins without prior knowledge of the molecular target.17−19 Aptamers generated by Cell-SELEX have shown high potential in diagnostics and therapeutics.20−22 For example, Sgc8, selected against protein tyrosine kinase 7 (PTK7), has been widely used for tumor imaging and targeted drug delivery .23,24 In addition, AS1411, a nucleolin-binding DNA aptamer, has entered phase II clinical trials for Variant Assay:Article Title: A Membrane-Retained DNA Aptamer Promotes Intracellular Platinum Accumulation and Chemosensitization in Ovarian Cancer. Article Snippet: .. Aptamers, short single-stranded DNA or RNA oligonucleotides selected through systematic evolution of ligands by exponential enrichment (SELEX), have emerged as a versatile class of molecular recognition agents.11−13 Compared with conventional antibodies, aptamers possess distinct advantages, such as low immunogenicity, ease of chemical modification, rapid tissue penetration, and scalable synthesis.14−16 CellSELEX, a SELEX variant employing intact living cells as targets, enables the selection of aptamers against native membrane proteins without prior knowledge of the molecular target.17−19 Aptamers generated by Cell-SELEX have shown high potential in diagnostics and therapeutics.20−22 For example, Sgc8, selected against protein tyrosine kinase 7 (PTK7), has been widely used for tumor imaging and targeted drug delivery .23,24 In addition, AS1411, a nucleolin-binding DNA aptamer, has entered phase II clinical trials for Selection:Article Title: A Membrane-Retained DNA Aptamer Promotes Intracellular Platinum Accumulation and Chemosensitization in Ovarian Cancer. Article Snippet: .. Aptamers, short single-stranded DNA or RNA oligonucleotides selected through systematic evolution of ligands by exponential enrichment (SELEX), have emerged as a versatile class of molecular recognition agents.11−13 Compared with conventional antibodies, aptamers possess distinct advantages, such as low immunogenicity, ease of chemical modification, rapid tissue penetration, and scalable synthesis.14−16 CellSELEX, a SELEX variant employing intact living cells as targets, enables the selection of aptamers against native membrane proteins without prior knowledge of the molecular target.17−19 Aptamers generated by Cell-SELEX have shown high potential in diagnostics and therapeutics.20−22 For example, Sgc8, selected against protein tyrosine kinase 7 (PTK7), has been widely used for tumor imaging and targeted drug delivery .23,24 In addition, AS1411, a nucleolin-binding DNA aptamer, has entered phase II clinical trials for Article Title: Article Snippet: .. Reference ID: 4217839 Article Title: Pan-genotypic agents against influenza virus and methods of using the same Article Snippet: .. Susceptibility of Influenza Viruses to Article Title: Trends, Gaps, and Challenges in Antiviral Resistance: A Bibliometric Analysis and Narrative Synthesis of Key Viruses, Resistance Mechanisms, and Drivers Article Snippet: Influenza A virus (Orthomyxoviridae) , Neuraminidase inhibitors (NAIs): oseltamivir, zanamivir; capdependent endonuclease inhibitor: baloxavir marboxil , NA: H275Y (N1 numbering); PA endonuclease: I38T/M/F , Reduced reduction in symptom duration and viral shedding; concern about transmission competent resistant strains in high risk settings. , [ – ] . .. Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) (Coronaviridae) , Article Title: Article Snippet: .. Section 1, Article Title: Article Snippet: .. Dose Selection: Article Title: Article Snippet: .. These substitutions included those detected in the resistance selection experiments, detected in the Membrane:Article Title: A Membrane-Retained DNA Aptamer Promotes Intracellular Platinum Accumulation and Chemosensitization in Ovarian Cancer. Article Snippet: .. Aptamers, short single-stranded DNA or RNA oligonucleotides selected through systematic evolution of ligands by exponential enrichment (SELEX), have emerged as a versatile class of molecular recognition agents.11−13 Compared with conventional antibodies, aptamers possess distinct advantages, such as low immunogenicity, ease of chemical modification, rapid tissue penetration, and scalable synthesis.14−16 CellSELEX, a SELEX variant employing intact living cells as targets, enables the selection of aptamers against native membrane proteins without prior knowledge of the molecular target.17−19 Aptamers generated by Cell-SELEX have shown high potential in diagnostics and therapeutics.20−22 For example, Sgc8, selected against protein tyrosine kinase 7 (PTK7), has been widely used for tumor imaging and targeted drug delivery .23,24 In addition, AS1411, a nucleolin-binding DNA aptamer, has entered phase II clinical trials for Generated:Article Title: A Membrane-Retained DNA Aptamer Promotes Intracellular Platinum Accumulation and Chemosensitization in Ovarian Cancer. Article Snippet: .. Aptamers, short single-stranded DNA or RNA oligonucleotides selected through systematic evolution of ligands by exponential enrichment (SELEX), have emerged as a versatile class of molecular recognition agents.11−13 Compared with conventional antibodies, aptamers possess distinct advantages, such as low immunogenicity, ease of chemical modification, rapid tissue penetration, and scalable synthesis.14−16 CellSELEX, a SELEX variant employing intact living cells as targets, enables the selection of aptamers against native membrane proteins without prior knowledge of the molecular target.17−19 Aptamers generated by Cell-SELEX have shown high potential in diagnostics and therapeutics.20−22 For example, Sgc8, selected against protein tyrosine kinase 7 (PTK7), has been widely used for tumor imaging and targeted drug delivery .23,24 In addition, AS1411, a nucleolin-binding DNA aptamer, has entered phase II clinical trials for Imaging:Article Title: A Membrane-Retained DNA Aptamer Promotes Intracellular Platinum Accumulation and Chemosensitization in Ovarian Cancer. Article Snippet: .. Aptamers, short single-stranded DNA or RNA oligonucleotides selected through systematic evolution of ligands by exponential enrichment (SELEX), have emerged as a versatile class of molecular recognition agents.11−13 Compared with conventional antibodies, aptamers possess distinct advantages, such as low immunogenicity, ease of chemical modification, rapid tissue penetration, and scalable synthesis.14−16 CellSELEX, a SELEX variant employing intact living cells as targets, enables the selection of aptamers against native membrane proteins without prior knowledge of the molecular target.17−19 Aptamers generated by Cell-SELEX have shown high potential in diagnostics and therapeutics.20−22 For example, Sgc8, selected against protein tyrosine kinase 7 (PTK7), has been widely used for tumor imaging and targeted drug delivery .23,24 In addition, AS1411, a nucleolin-binding DNA aptamer, has entered phase II clinical trials for Clinical Proteomics:Article Title: A Membrane-Retained DNA Aptamer Promotes Intracellular Platinum Accumulation and Chemosensitization in Ovarian Cancer. Article Snippet: .. Aptamers, short single-stranded DNA or RNA oligonucleotides selected through systematic evolution of ligands by exponential enrichment (SELEX), have emerged as a versatile class of molecular recognition agents.11−13 Compared with conventional antibodies, aptamers possess distinct advantages, such as low immunogenicity, ease of chemical modification, rapid tissue penetration, and scalable synthesis.14−16 CellSELEX, a SELEX variant employing intact living cells as targets, enables the selection of aptamers against native membrane proteins without prior knowledge of the molecular target.17−19 Aptamers generated by Cell-SELEX have shown high potential in diagnostics and therapeutics.20−22 For example, Sgc8, selected against protein tyrosine kinase 7 (PTK7), has been widely used for tumor imaging and targeted drug delivery .23,24 In addition, AS1411, a nucleolin-binding DNA aptamer, has entered phase II clinical trials for Drug discovery:Article Title: Article Snippet: .. Reference ID: 4217839 Passaging:Article Title: Pan-genotypic agents against influenza virus and methods of using the same Article Snippet: .. Susceptibility of Influenza Viruses to Protease Inhibitor:Article Title: Trends, Gaps, and Challenges in Antiviral Resistance: A Bibliometric Analysis and Narrative Synthesis of Key Viruses, Resistance Mechanisms, and Drivers Article Snippet: Influenza A virus (Orthomyxoviridae) , Neuraminidase inhibitors (NAIs): oseltamivir, zanamivir; capdependent endonuclease inhibitor: baloxavir marboxil , NA: H275Y (N1 numbering); PA endonuclease: I38T/M/F , Reduced reduction in symptom duration and viral shedding; concern about transmission competent resistant strains in high risk settings. , [ – ] . .. Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) (Coronaviridae) , Bioprocessing:Article Title: Trends, Gaps, and Challenges in Antiviral Resistance: A Bibliometric Analysis and Narrative Synthesis of Key Viruses, Resistance Mechanisms, and Drivers Article Snippet: Influenza A virus (Orthomyxoviridae) , Neuraminidase inhibitors (NAIs): oseltamivir, zanamivir; capdependent endonuclease inhibitor: baloxavir marboxil , NA: H275Y (N1 numbering); PA endonuclease: I38T/M/F , Reduced reduction in symptom duration and viral shedding; concern about transmission competent resistant strains in high risk settings. , [ – ] . .. Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) (Coronaviridae) , Infection:Article Title: Article Snippet: .. Dose Selection: |
